LIBTAYO can help your
immune system fight
advanced CSCC

What is LIBTAYO?

LIBTAYO is a medicine approved by the Food and Drug Administration (FDA) to treat cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation.

What is immunotherapy?

Immunotherapy can help the body’s immune system fight cancer. LIBTAYO is a type of immunotherapy treatment called a programmed death receptor-1 (PD-1) inhibitor. LIBTAYO is not chemotherapy or radiation therapy.

Is LIBTAYO right for me?

LIBTAYO may be right for people with advanced CSCC that:

has spread (metastasized)

OR

cannot be
cured by surgery or radiation

Ask your healthcare provider whether LIBTAYO is a treatment option you should consider.

Meaningful Stories.
Meaningful Hope.

Actual patient. Individual results may vary.

Meet Chris

Chris shares her story about living with metastatic CSCC. Listen as she takes you through her journey, from initially being misdiagnosed to the chaIlenges she faces managing life with metastatic CSCC, and her treatment experience with LIBTAYO.

Please see full Prescribing Information, including Medication Guide.

Actual patient. Individual results may vary.

Meet Dave

Hear from Dave as he takes you through his journey with advanced CSCC. Dave underwent many forms of treatment, including surgery and radiation. Learn more about how treatment with LIBTAYO helped Dave when surgery and radiation were no longer options for him.

Download Dave's story